Supernus Pharmaceuticals (SUPN) Non-Current Debt (2011 - 2021)
Supernus Pharmaceuticals (SUPN) reported Non-Current Debt of $379.3 million for Q4 2021, up 4655.51% quarter-over-quarter from $8.0 million in Q1 2013.
Supernus Pharmaceuticals (SUPN) Non-Current Debt (2011 - 2021) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 4 years of Non-Current Debt data on file, last reported at $379.3 million in Q4 2021.
- Non-Current Debt for Q4 2021 came in at $379.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $379.3 million (changed N/A YoY), and the FY2021 annual result was $379.3 million, changed N/A from the prior year.
- Non-Current Debt improved to $379.3 million in Q4 2021 per SUPN's latest filing, from $8.0 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $379.3 million in Q4 2021 and troughed at $379.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Supernus Pharmaceuticals | 2.63 Bn | 2.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 379.25 Mn |
| Dec 31, 2021 | 379.25 Mn |
| Mar 31, 2013 | 7.98 Mn |
| Mar 31, 2013 | 7.98 Mn |
| Dec 31, 2012 | 11.09 Mn |
| Dec 31, 2012 | 11.09 Mn |
| Sep 30, 2012 | 14.12 Mn |
| Sep 30, 2012 | 14.12 Mn |
| Jun 30, 2012 | 17.06 Mn |
| Jun 30, 2012 | 17.06 Mn |
| Mar 31, 2012 | 19.93 Mn |
| Mar 31, 2012 | 19.93 Mn |
| Dec 31, 2011 | 22.71 Mn |
| Dec 31, 2011 | 22.71 Mn |